skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Modulation of complement component biosynthesis by human lung cells

Thesis/Dissertation ·
OSTI ID:6030261

Research has focused on evaluating the capability of lung tissue cells to biosynthesize complement components in vitro, and the regulation of this production, utilizing cell lines of human type II pneumocytes (A549) and lung fibrblasts (WI-38). Initially complement biosynthesis was directly demonstrated by incorporation of /sup 35/S-methionine into immunoprecipitable complement components and regulatory proteins. Using this procedure, synthesis of Clr, Cls, C4, C3, C5, C6, C7, C8, C9, Factors B, H, I and Cls inactivator by A549 was detected, but not Clq or albumin. Quantitative evaluation of the kinetics of C3 and C5 production demonstrated that A549 produced antigenic C3, antigenic C5 and functional C5. In contrast, the WI-38 produced C3 and C5 at 30 percent the rates determined for A549. The effects of exogenous agents and endogenous factors to modulate complement component production by A549 and WI-38 were evaluated.

Research Organization:
Connecticut Univ., Storrs (USA)
OSTI ID:
6030261
Resource Relation:
Other Information: Thesis (Ph. D.)
Country of Publication:
United States
Language:
English